AKT1 and neoplasm: [28] Galectin-1 (Gal1), a β-galactoside-binding protein abundantly expressed in tumor microenvironments, induced E-cadherin downregulation and triggered EMT through a PI3K/Akt-dependent mechanism in human hepatocellular carcinoma cells.